News Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse Staff September 11, 2023 Iframe sync Post Navigation Previous APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)Next Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer More Stories Clinical Trial Heart Attack News Pharmaceutical Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025) Staff May 24, 2025 Cancer News ZLNA – Issuance of shares through set-off of option exercise fee Staff May 24, 2025 News BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. Staff May 24, 2025
